David B. Meya

9.6k total citations · 1 hit paper
210 papers, 5.2k citations indexed

About

David B. Meya is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, David B. Meya has authored 210 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Epidemiology, 163 papers in Infectious Diseases and 24 papers in Surgery. Recurrent topics in David B. Meya's work include Fungal Infections and Studies (138 papers), Antifungal resistance and susceptibility (127 papers) and Nail Diseases and Treatments (51 papers). David B. Meya is often cited by papers focused on Fungal Infections and Studies (138 papers), Antifungal resistance and susceptibility (127 papers) and Nail Diseases and Treatments (51 papers). David B. Meya collaborates with scholars based in Uganda, United States and United Kingdom. David B. Meya's co-authors include David R. Boulware, Radha Rajasingham, Joshua Rhein, Paul R. Bohjanen, Andrew Kambugu, Darlisha A Williams, Abdu K Musubire, Edward N. Janoff, Melissa A. Rolfes and Richard Kwizera and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

David B. Meya

200 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis

2022 298 citations Radha Rajasingham, David B. Meya et al. profile →

Peers

Countries citing papers authored by David B. Meya

Since Specialization

Citations

This map shows the geographic impact of David B. Meya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Meya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Meya more than expected).

Fields of papers citing papers by David B. Meya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Meya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Meya. The network helps show where David B. Meya may publish in the future.

Co-authorship network of co-authors of David B. Meya

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Meya. A scholar is included among the top collaborators of David B. Meya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Meya. David B. Meya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda 2025 ·HIV Medicine ·Eva Laker, Melanie R. Nicol, (unknown), (unknown), Allan Buzibye, (unknown), Mike Kesby, Matthew T. G. Holden, (unknown), David B. Meya, Barbara Castelnuovo, Derek J. Sloan, Christine Sekaggya‐Wiltshire	1
2	The hypervirulent Type-1/Type-17 phenotype of Cryptococcus neoformans clinical isolates is specific to A/J mice 2025 ·Infection and Immunity ·(unknown), (unknown), (unknown), Thamotharampillai Dileepan, David B. Meya, Kirsten Nielsen	0
3	Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System Compartments 2024 ·The Journal of Infectious Diseases ·Fan Wang, (unknown), (unknown), (unknown), James Fisher, David B. Meya, MaryPeace McRae, David R. Boulware, Robert Lukande, Melanie R. Nicol	2
4	Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis 2024 ·The Journal of Infectious Diseases ·Elizabeth C Okafor, Liliane Mukaremera, Kathy Huppler Hullsiek, Nicole Engen, Lillian Tugume, Kenneth Ssebambulidde, Abdu K Musubire, Edwin Nuwagira, Edward Mpoza, Darlisha A Williams, Conrad Muzoora, Joshua Rhein, David B. Meya, Kirsten Nielsen, David R. Boulware	1
5	Poor long-term outcomes despite improved hospital survival for patients with cryptococcal meningitis in rural, Northern Uganda 2024 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Joshua Rhein, David B. Meya, (unknown), Paul R. Bohjanen	0
6	Lack of education, knowledge, and supplies are barriers to cryptococcal meningitis care among nurses and other healthcare providers in rural Uganda: A mixed methods study 2023 ·Nurse Education Today ·(unknown), (unknown), Sarah Iribarren, David B. Meya, Paul R. Bohjanen, Danuta Kasprzyk	2
7	Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia 2023 ·Open Forum Infectious Diseases ·(unknown), Elizabeth Nalintya, (unknown), Paul Kirumira, (unknown), (unknown), (unknown), Caleb P Skipper, David B. Meya, David R. Boulware, Radha Rajasingham	2
8	Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV 2023 ·Open Forum Infectious Diseases ·Jayne Ellis, Ananta Bangdiwala, Caleb P Skipper, Lillian Tugume, (unknown), (unknown), Katelyn A Pastick, Kenneth Ssebambulidde, Bożena M Morawski, Abdu K Musubire, Mark R. Schleiss, David Moore, Joseph N Jarvis, David R. Boulware, David B. Meya, Barbara Castelnuovo	3
9	Prevalence and Factors Associated With Cryptoccocal Antigenemia Among Patients With Advanced Human Immunodeficiency Virus in Eastern Uganda: A Facility-Based Cross-sectional Study 2023 ·Open Forum Infectious Diseases ·(unknown), Peter Olupot‐Olupot, (unknown), David B. Meya, (unknown)	1
10	The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda 2022 ·PLoS neglected tropical diseases ·David S. Lawrence, Agnes Ssali, (unknown), (unknown), (unknown), Thomas S. Harrison, David B. Meya, Joseph N Jarvis, Janet Seeley	6
11	High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study 2022 ·HIV Medicine ·Eva Laker, Fiona V Cresswell, (unknown), (unknown), (unknown), Mohammed Lamorde, Catriona Waitt, David B. Meya, Agnes Kiragga	4
12	Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review 2022 ·Open Forum Infectious Diseases ·Katelyn A Pastick, Enock Kagimu, (unknown), Kenneth Ssebambulidde, (unknown), (unknown), (unknown), David B. Meya, David R. Boulware, Fiona V Cresswell, Nathan C. Bahr	4
13	High Burden of Cryptococcal Meningitis Among Antiretroviral Therapy–Experienced Human Immunodeficiency Virus–Infected Patients in Northern Uganda in the Era of “Test and Treat”: Implications for Cryptococcal Screening Programs 2022 ·Open Forum Infectious Diseases ·(unknown), (unknown), Joshua Rhein, (unknown), (unknown), (unknown), (unknown), David B. Meya, Paul R. Bohjanen	12
14	Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? 2022 ·Open Forum Infectious Diseases ·Enock Kagimu, Nicole Engen, Kenneth Ssebambulidde, John Kasibante, (unknown), Edward Mpoza, Lillian Tugume, Edwin Nuwagira, (unknown), Darlisha A Williams, Kathy Huppler Hullsiek, David R. Boulware, David B. Meya, Joshua Rhein, Mahsa Abassi, Abdu K Musubire	11
15	COVID-19 and the HIV care continuum in Uganda: minimising collateral damage 2021 ·SHILAP Revista de lepidopterología ·Enock Kagimu, Emily Martyn, (unknown), John Kasibante, Morris K Rutakingirwa, Richard Kwizera, Kenneth Ssebambulidde, Darlisha A Williams, Jayne Ellis, Fiona V Cresswell, David B. Meya	1
16	Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis 2020 ·Clinical Infectious Diseases ·Mahsa Abassi, Ananta Bangdiwala, Edwin Nuwagira, Kiiza Kandole Tadeo, Michael Okirwoth, Darlisha A Williams, Edward Mpoza, Lillian Tugume, Kenneth Ssebambulidde, Kathy Huppler Hullsiek, Abdu K Musubire, Conrad Muzoora, Joshua Rhein, David B. Meya, David R. Boulware	16
17	Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co‐infection 2020 ·Mycoses ·(unknown), David R. Boulware, Joseph Olobo, David B. Meya	22
18	Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection 2019 ·mBio ·Aleeza C. Gerstein, (unknown), Tami McDonald, Yina Wang, (unknown), (unknown), Kyle D. Smith, Andrew Akampurira, David B. Meya, Chaoyang Xue, David R. Boulware, Kirsten Nielsen	41
19	The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence 2019 ·Infection and Immunity ·Liliane Mukaremera, Tami McDonald, Judith N. Nielsen, (unknown), Andrew Akampurira, Charlotte Schutz, Kabanda Taseera, Conrad Muzoora, Graeme Meintjes, David B. Meya, David R. Boulware, Kirsten Nielsen	41
20	Cryptococcal Genotype Influences Immunologic Response and Human Clinical Outcome after Meningitis 2012 ·mBio ·Darin L. Wiesner, (unknown), Jennifer Corcoran, Tami McDonald, Melissa A. Rolfes, David B. Meya, Henry Kajumbula, Andrew Kambugu, Paul R. Bohjanen, Joseph Knight, David R. Boulware, Kirsten Nielsen	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact